The emerging patent landscape of CRISPR–Cas gene editing technology
NATURE BIOTECHNOLOGY(2016)
Abstract
Early views on the control of the CRISPR–Cas disruptive enabling technology and access for follow-on commercial applications.
MoreTranslated text
Key words
Intellectual-property rights,RNAi,Life Sciences,general,Biotechnology,Biomedicine,Agriculture,Biomedical Engineering/Biotechnology,Bioinformatics
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined